Fansidar

Fansidar

a trademark for a fixed-combination antimalarial agent (pyrimethamine and sulfadoxine).

Fansidar

A brand name for a mixture of PYRIMETHAMINE and SULFADOXINE.

Sulfadoxone/pyrimethamine (Fansidar)

An antimalarial drug developed in the 1960s. It is the first drug tried in some parts of the world where chloroquine resistance is widespread. It has been associated with severe allergic reactions due to its sulfa component.
Mentioned in: Malaria
References in periodicals archive ?
Chloroquine (CQ), introduced in Kenya in 1930s, remained the first-line malaria treatment until 1998 when it was officially replaced by sulphadoxine-pyrimethamine (SP) based drugs such as Fansidar.
71) They found that Pfalciparum from both Solomon Islands and Vanuatu had high levels of resistance to Chloroquine (72) and Fansidar.
14,18,27,35) Prevention of TE in HIV patients involves two major strategies, the first is directed at instituting primary prophylaxis with TMP/SMX, pyrimethamine/dapsone, and Fansidar to patients who are toxoplasma seropositive.
A 33 year old man took a single tablet of Fansidar (sulfadoxine and pyrimethamine) and chloroquine in preparation for a trip to Pakistan.
Finally, beginning in 1969, the DRV relied on pyrimethamine (daraprim), sulfamid slow-acting pills 3 and 2, and Fansidar, a sulfadoxine and pyrimethamine mix, which works for falciparum albeit with serious side effects.
Fansidar in 25 mg/kg concentration (100 [micro]l) were fed by gavage every day for 12 days after infection in malaria mice.
Malaria parasites also exhibit resistance to Fansidar, a treatment involving Sulfadoxine and Pyrimethamine, that act inhibiting the formation of nucleic acids (Bloland 2001, Hastings 2004, Kakkilaya 2008).
Resistance to other antimalarial drugs, such as chloroquine and fansidar, has previously spread from Southeast Asia to Africa, providing a chilling precedent for such a scenario.
They are instead using fansidar or oridar - an old line medication that is now useless against many strains of the parasite.
all resistant cases were of RI level and responded to Fansidar treatments (Table III).
Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes.